ReviewCancer journal (Sudbury, Mass.)

New Combination Strategies Using Programmed Cell Death 1/Programmed Cell Death Ligand 1 Checkpoint Inhibitors as a Backbone.

Siwen Hu-Lieskovan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.